The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Remyelination of primary demyelinated lesions is a common feature of experimental models of multiple sclerosis (MS) and is also suggested to be the normal response to demyelination during the early stages of MS itself. Many lines of evidence have shown that remyelination is preceded by the division of endogenous oligodendrocyte precursor cells (OPCs) in the lesion and its borders. It is suggested that this rapid response of OPCs to repopulate the lesion site and their subsequent differentiation into new oligodendrocytes is the key to the rapid remyelination. Antibodies to the NG2 chondroitin sulphate proteoglycan have proved exceedingly useful in following and quantitating the response of endogenous OPCs to demyelination. Here we review the literature on the response of NG2-expressing OPCs to demyelination and provide some new evidence on their response to the chronic inflammatory demyelinating environment seen in recombinant myelin oligodendrocyte glycoprotein (MOG) induced experimental allergic encephalomyelitis (EAE) in the DA rat. NG2-expressing OPCs responded to the inflammatory demyelination in this model by becoming reactive and increasing in number in a very focal manner. Evidence of NG2+ OPCs in lesioned areas beginning to express the oligodendrocyte marker CNP was also seen. The response of OPCs appeared to occur following successive relapses but did not always lead to remyelination, with areas of chronic demyelination observed in the spinal cord. The presence of OP…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, oligodendrocyte progenitor cells (OPCs) are a population of adult stem cells responsible for mediating CNS myelin repair in demyelinating conditions such as MS [113,114].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [113]
Citations
Cites
Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus
Bergles, D. E., Roberts, J. D. B., Somogyi, P., & Jahr, C. E. (2000) · Nature · doi:10.1038/35012083 · Cited by 1,059
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Dawson, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00210-0 · Cited by 927
Self-citationMultiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord
Horner, P. J., Power, A. E., Kempermann, G., Kuhn, H. G., Palmer, T. D., Winkler, J., Thal, L. J., & Gage, F. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02218.2000 · Cited by 777
NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J., Prineas, J., & Trapp, B. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 712
Notch Receptor Activation Inhibits Oligodendrocyte Differentiation
Wang, S., Sdrulla, A. D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Weinmaster, G., & Barres, B. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80515-2 · Cited by 705
The oligodendrocyte precursor cell in health and disease
Levine, J. M., Reynolds, R., & Fawcett, J. W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01691-x · Cited by 672
Self-citationNishiyama, A., Lin, X.-H., Giese, N., Heldin, C.-H., & Stallcup, W. B. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960201)43:3<299::aid-jnr5>3.0.co;2-e · Cited by 630
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
“This activation is the first step in the remyelination process and involves not only changes in morpholog”
BackgroundDawson, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00210-0 · Cited by 927
Self-citationPolydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
“However, recent publications indicate that the number of OPCs is reduced over time in multiple sclerosis lesions (Chang et al., 2002; Reynolds et al., 2002; Wolswijk 2002; Wilson et al., 2006).”
BackgroundResultNG2 cells generate both oligodendrocytes and gray matter astrocytes
Zhu, X., Bergles, D. E., & Nishiyama, A. (2008) · Development · doi:10.1242/dev.004895 · Cited by 683
“NG2 glia constitute a fourth major glial cell type in the mammalian central nervous system (CNS) that is distinct from other cell types.”
BackgroundInfluentialMi, S., Hu, B., Hahm, K., Luo, Y., Kam Hui, E. S., Yuan, Q., Wong, W. M., Wang, L., Su, H., Chu, T.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1664 · Cited by 492
The life, death, and replacement of oligodendrocytes in the adult CNS
McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 455
“…well, including hypomyelination and demyelination (Carroll et al. 1998; Keirstead et al. 1998; Redwine and Armstrong 1998; Levine and Reynolds 1999; Reynolds et al. 2002; Bu et al. 2004), trauma (Levine 1994; Amat et al. 1998; McTigue et al. 2001; Hampton et al. 2004; Zai and Wrathall 2005),…”
BackgroundAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Furthermore, oligodendrocyte progenitor cells (OPCs) are a population of adult stem cells responsible for mediating CNS myelin repair in demyelinating conditions such as MS [113,114].”
BackgroundSelf-citationA functional role for EGFR signaling in myelination and remyelination
Aguirre, A., Dupree, J. L., Mangin, J. M., & Gallo, V. (2007) · Nature Neuroscience · doi:10.1038/nn1938 · Cited by 352
“Similar progenitors are found in multiple sclerosis lesion”
BackgroundEdg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4645-04.2005 · Cited by 338
Remyelination can be extensive in multiple sclerosis despite a long disease course
Patani, R., Balaratnam, M., Vora, A., & Reynolds, R. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00805.x · Cited by 318
Self-citationNG 2‐glia and their functions in the central nervous system
Dimou, L., & Gallo, V. (2015) · Glia · doi:10.1002/glia.22859 · Cited by 260
“, 1998; Levine and Reynolds, 1999), and undergoing rapid proliferation (Di Bello et al., 1999; Reynolds et al., 2002) and differentiation into myelinating oligodendrocytes (Franklin et al.”
Cell cycle dynamics of NG2 cells in the postnatal and ageing brain
Psachoulia, K., Jamen, F., Young, K. M., & Richardson, W. D. (2009) · Neuron Glia Biology · doi:10.1017/s1740925x09990354 · Cited by 257
“…focal demyelination and subsequent re-myelination in mouse spinal cord, the dynamic behaviour of NG2 cells in and around the lesion suggests that they are the source of remyelinating oligodendrocytes (Keirstead et al. , 1998; Reynolds et al. , 2002; Watanabe et al. , 2002; Dawson et al. , 2003).”
BackgroundPolito, A., & Reynolds, R. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00454.x · Cited by 231
“…NG2+ cell number decreases upon onset of remyelination, suggesting that at least some of the NG2+ cells have developed into oligodendrocytes (Levine & Reynolds, 1999; Reynolds et al. 2002; Watanabe et al. 2002), although the degree of apoptosis in this cell population has yet to be investigated.”
BackgroundSelf-citationSemaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Williams, A., Piaton, G., Aigrot, M.-S., Belhadi, A., Theaudin, M., Petermann, F., Thomas, J.-L., Zalc, B., & Lubetzki, C. (2007) · Brain · doi:10.1093/brain/awm202 · Cited by 227
“Recent data have demonstrated that such oligodendrocyte precursor cells persist in the adult murine brain, as well as in normal human and MS brain (Chang et al., 2002; Reynolds et al., 2002; Wilson et al., 2006).”
BackgroundCXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination
Patel, J. R., McCandless, E. E., Dorsey, D., & Klein, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006301107 · Cited by 231
“The presence of OPCs withinMS lesions (35) suggests that the recruitment of these precursors remains intact.”
BackgroundTalbott, J. F., Loy, D. N., Liu, Y., Qiu, M. S., Bunge, M. B., Rao, M. S., & Whittemore, S. R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.038 · Cited by 194
“Several subsequent studies have confirmed the capacity for remyelination by endogenous progenitors, with particular emphasis on the proliferative response to demyelination by oligodendrocyte precursor cells (OPCs) (Carroll et al., 1998; Di Bello et al., 1999; Keirstead et al., 1998; Levine and Reynolds, 1999; Redwine…”
BackgroundSynantocytes: the fifth element
Butt, A. M., Hamilton, N., Hubbard, P., Pugh, M., & Ibrahim, M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00458.x · Cited by 201
Kim, E. J., Leung, C. T., Reed, R. R., & Johnson, J. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3178-07.2007 · Cited by 162
“Adult OPCs are identified by PDGFR or NG2 and constitute the major dividing cell population contributing to myelination repair in response to brain injury (Chari and Blakemore, 2002; Reynolds et al., 2002; Dawson et al., 2003; Woodruff et al., 2004; Polito and Reynolds, 2005).”
BackgroundThe T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration
Dugas, J. C., Ibrahim, A., & Barres, B. A. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.03.007 · Cited by 167
“…lesions where mature myelin is lost, the small numbers of residual, undifferentiated adult OPCs nearby begin to proliferate, enabling the production of newly generated OLs that subsequently remyelinate denuded axons (McTigue and Tripathi, 2008; Redwine and Armstrong, 1998; Reynolds et al., 2002).”
BackgroundCsf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery
Nissen, J. C., Thompson, K. K., West, B. L., & Tsirka, S. E. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.021 · Cited by 168
“OPCs become recruited in MS/EAE lesions (Chang et al., 2000; 2002; Di Bello et al., 1999) and do not gather in normal-appearing white matter (Reynolds et al., 2002).”
InfluentialPolydendrocytes: NG2 Cells with Many Roles in Development and Repair of the CNS
Nishiyama, A. (2007) · The Neuroscientist · doi:10.1177/1073858406295586 · Cited by 162
Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies
Sakariassen, P. Ø., Immervoll, H., & Chekenya, M. (2007) · Neoplasia · doi:10.1593/neo.07658 · Cited by 158
“to CNS injury [44–46].”
Gardner, C., Magliozzi, R., Durrenberger, P. F., Howell, O. W., Rundle, J., & Reynolds, R. (2013) · Brain · doi:10.1093/brain/awt279 · Cited by 148
“Recombinant mouse MOG was expressed in Escherichia coli and purified as described previously (Reynolds et al., 2002).”
MethodSelf-citationNG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis
Zhang, S.-Z., Wang, Q.-Q., Yang, Q.-Q., Gu, H.-Y., Yin, Y.-Q., Li, Y.-D., Hou, J.-C., Chen, R., Sun, Q.-Q., Sun, Y.-F., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1439-x · Cited by 135
“This assumption is supported by the evidence that NG2 glia exist broadly in the white and gray matter of the adult CNS and are almost as numerous as astrocytes [59], suggesting that the newly revealed function for NG2 glia in this study is highly correlated with its distribution pattern in the CNS.”
Rhodes, K. E., Raivich, G., & Fawcett, J. W. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.055 · Cited by 152
Astrocytes and NG2‐glia: what's in a name?
Nishiyama, A., Yang, Z., & Butt, A. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00489.x · Cited by 125
“There is a large body of evidence that NG2-glia generate myelinating oligodendrocytes (Horner et al. 2000; Nishiyama et al. 2002; Reynolds et al. 2002), but NG2-glia persist in large numbers long after oligodendrocytes are generated.”
BackgroundNG2‐expressing cells in the nervous system revealed by the NG2‐EYFP‐knockin mouse
Karram, K., Goebbels, S., Schwab, M., Jennissen, K., Seifert, G., Steinhäuser, C., Nave, K., & Trotter, J. (2008) · genesis · doi:10.1002/dvg.20440 · Cited by 127
Wilson, H., Scolding, N. J., & Raine, C. S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.014 · Cited by 143
Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia
Bannerman, P., Hahn, A., Soulika, A., Gallo, V., & Pleasure, D. (2007) · Glia · doi:10.1002/glia.20437 · Cited by 112
“…is generally believed to be adult oligodendroglial progenitor cells that have survived within the inflammatory lesions or persisted in neighboring uninflamed white matter (Armstrong et al., GLIA DOI 10.1002/glia 1990; Cenci di Bello et al., 1999; Reynolds et al., 2002; Wolswijk and Noble, 1992).”
BackgroundInfluentialPapadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Self-citationAharoni, R., Herschkovitz, A., Eilam, R., Blumberg-Hazan, M., Sela, M., Bruck, W., & Arnon, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804632105 · Cited by 111
“Thus, it has been demonstrated that in response to stimuli such as inflammation or demyelination, OPCs, characterized by bipolar morphology and by the presence of the early marker chondroitin sulfate proteoglycan, NG2, undergo proliferation and transform into multiprocessed preoligodendrocytes that acquire the later c…”
BackgroundResultEhninger, D., Wang, L.-P., Klempin, F., Römer, B., Kettenmann, H., & Kempermann, G. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1200-z · Cited by 103
“Mouse (C57BL6/J)”
BackgroundFunctions of optic nerve glia: axoglial signalling in physiology and pathology
Butt, A. M., Pugh, M., Hubbard, P. S., & James, G. (2004) · Eye · doi:10.1038/sj.eye.6701595 · Cited by 117
Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White Matter
Vana, A. C., Flint, N. C., Harwood, N. E., Le, T. Q., Fruttiger, M., & Armstrong, R. C. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d46 · Cited by 101
“With prolonged disease duration, depletion of the OP and premyelinating oligodendrocyte populations may limit the capacity for remyelination of chronic lesions (4, 5, 8, 9).”
BackgroundRemyelination: The True Regeneration of the Central Nervous System
Crawford, A. H., Chambers, C., & Franklin, R. J. M. (2013) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2013.05.004 · Cited by 113
“The activation process involves changes in OPC morphology (Levine and Reynolds, 1999;Reynolds et al., 2002), as well as the up-regulation of several genes.”
BackgroundWnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain
Yuan, S., Shi, Y., & Tang, S. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9370-3 · Cited by 102
“Because new oligodendrocytes were known to be generated in EAE models and Wnt signaling was suggested to play critical roles in this process (Reynolds et al. 2002; Tripathi et al. 2010), we tested if the increased Wnt3a-expressing non-neuronal cells were oligodendrocytes.”
Baxi, E. G., DeBruin, J., Jin, J., Strasburger, H. J., Smith, M. D., Orthmann‐Murphy, J. L., Schott, J. T., Fairchild, A. N., Bergles, D. E., & Calabresi, P. A. (2017) · Glia · doi:10.1002/glia.23229 · Cited by 97
“…to be the source of new oligodendrocytes following demyelination (Di Bello, Dawson, Levine, & Reynolds, 1999; Levine, Stincone, & Lee, 1993; Reynolds et al., 2002), this hypothesis was confirmed when in vivo genetic labeling of OPCs revealed that they are mobilized after demyelination and…”
BackgroundAhmed, Z., Asi, Y. T., Lees, A. J., Revesz, T., & Holton, J. L. (2013) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00637.x · Cited by 92
Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia
Mauney, S. A., Pietersen, C. Y., Sonntag, K.-C., & Woo, T.-U. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.042 · Cited by 99
“CNPase (2’,3’-cyclic nucleotide 3’phosphodiesterase) was chosen as a marker, because it is expressed in OPCs in addition to differentiating and myelinating oligodendrocytes (Belachew et al., 2001; Dawson, 2003; Levine et al., 1993; Polito and Reynolds, 2005; Reynolds et al., 2002; Scherer et al., 1994; Sprinkle, 1989;…”
BackgroundMethodNG2 cells are distinct from neurogenic cells in the postnatal mouse subventricular zone
Komitova, M., Zhu, X., Serwanski, D. R., & Nishiyama, A. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21917 · Cited by 92
“…into oligodendrocytes in vitro (Levine and Stallcup, 1987; Stallcup and Beasley, 1987) and in vivo in developing and adult CNS (Horner et al., 2000; Bu et al., 2004; Zhu et al., 2008) and after a demyelinating injury (Reynolds et al., 2002; Watanabe et al., 2002; Polito and Reynolds, 2005).”
BackgroundBoulanger, J. J., & Messier, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.063 · Cited by 111
“The number of new OPCs produced during proliferation approximates the number of OPCs required to remyelinate a given demyelinated area (Levine and Reynolds, 1999, Reynolds et al., 2002).”
InfluentialM., F., S., P., M., M., L., G., & L., C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03664.x · Cited by 91
“NG2 has been proposed as a marker of proliferating OPCs by some authors (Reynolds et al., 2002; Chen et al., 2003) but is proposed controversial by others (Butt et al., 2003; Horner et al., 2003).”
BackgroundGap junction pathology in multiple sclerosis lesions and normal-appearing white matter
Markoullis, K., Sargiannidou, I., Schiza, N., Hadjisavvas, A., Roncaroli, F., Reynolds, R., & Kleopa, K. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0978-4 · Cited by 91
Self-citationMultiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender
Kipp, M., Amor, S., Krauth, R., & Beyer, C. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.01.001 · Cited by 91
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis
Markoullis, K., Sargiannidou, I., Gardner, C., Hadjisavvas, A., Reynolds, R., & Kleopa, K. A. (2012) · Glia · doi:10.1002/glia.22334 · Cited by 87
“…(end volume: 2.5mg/mL) of mouse recombinant myelin oligodendrocyte glycoprotein (rMOG) and an equal volume of Complete Freund’s Adjuvant (CFA) mixed with 5 mg/mL desiccated Mycobacterium tuberculosis (Difco Laboratories, Detroit). rMOG was produced as previously described (Reynolds et al., 2002).”
MethodSelf-citationMadeira, A., Burgelin, I., Perron, H., Curtin, F., Lang, A. B., & Faucard, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.006 · Cited by 87
“Its failure culminates in MS, in particular in its progressive forms (Aharoni et al., 2008; Baumann and Pham-Dinh, 2001; Bruck et al., 2003; Keough and Yong, 2013; Polito and Reynolds, 2005; Reynolds et al., 2002).”
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 79
“Adult oligodendrocyte progenitor cells (OPCs) comprising 5–10% of all CNS cells are primarily responsible for carrying out myelin repair following demyelinating events (Reynolds et al., 2002; Tripathi et al., 2010).”
BackgroundSelf-citationExtracellular cues influencing oligodendrocyte differentiation and (re)myelination
Wheeler, N. A., & Fuss, B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.019 · Cited by 92
“[PubMed: 26134004] Etxeberria A, Mangin JM, Aguirre A, Gallo V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum.”
InfluentialTalbott, J. F., Cao, Q., Enzmann, G. U., Benton, R. L., Achim, V., Cheng, X. X., Mills, M. D., Rao, M. S., & Whittemore, S. R. (2006) · Glia · doi:10.1002/glia.20369 · Cited by 79
“Numerous studies using a variety of experimental injury paradigms have identified a widespread population of endogenous oligodendrocyte precursor cells (OPCs) as a likely source for new oligodendrocyte myelin in the adult (Carroll et al., 1998; Gensert and Goldman, 1997; Keirstead et al., 1998; Levine and Reynolds, 19…”
BackgroundHooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35734-4 · Cited by 72
Zhang, J., Zhang, Z. G., Morris, D., Li, Y., Roberts, C., Elias, S. B., & Chopp, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.054 · Cited by 77
“…(Raine et al., 1988, Carroll and Jennings, 1994, Gensert and Goldman, 1997, Carroll et al., 1998, Scolding et al., 1998, Wolswijk, 1998, Reynolds et al., 2002, Wolswijk, 2002), and endogenous OPCs represent a viable target for therapies intended to enhance remyelination in MS patients.”
BackgroundLecca, D., Marangon, D., Coppolino, G. T., Méndez, A. M., Finardi, A., Costa, G. D., Martinelli, V., Furlan, R., & Abbracchio, M. P. (2016) · Scientific Reports · doi:10.1038/srep34503 · Cited by 77
Loulier, K., Ruat, M., & Traiffort, É. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03896.x · Cited by 81
“Taken together with the persistence of NG2+ cells observed in an experimental autoimmune encephalomyelitis animal model (Reynolds et al. 2002) or in demyelinating plaques of multiple sclerosis patients (Chang et al. 2000), the proliferative effect of Shh on NG2+ cells and its transcriptional effect…”
BackgroundAharoni, R., Vainshtein, A., Stock, A. D., Eilam, R., From, R., Shinder, V., & Arnon, R. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.06.003 · Cited by 82
The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis
Nonneman, A., Robberecht, W., & Bosch, L. V. D. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.21 · Cited by 85
Gauthier, M., Kosciuczyk, K., Tapley, L., & Karimi‐Abdolrezaee, S. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12268 · Cited by 81
“…OPCs does not always translate into adequate remyelination in © 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd European Journal of Neuroscience, 38, 2693–2715 chronic multiple sclerosis lesions (Franklin, 2002; Reynolds et al., 2002; Franklin & Ffrench-Constant, 2008).”
BackgroundCytology and lineage of NG2-positive glia
Berry, M., Hubbard, P. S., & Butt, A. M. (2002) · Journal of Neurocytology · doi:10.1023/a:1025735513560 · Cited by 78
NG2 cells, a new trail for Alzheimer’s disease mechanisms?
Nielsen, H. M., Ek, D., Avdic, U., Orbjörn, C., Hansson, O., Bank, T. N. B., Veerhuis, R., Rozemuller, A. J., Brun, A., Minthon, L., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-7 · Cited by 71
“This is supported by the observed loss of NG2 cells and changes in NG2 cell morphology that correlate to disease severity in multiple sclerosis (MS) brain [5,17,18].”
BackgroundMaier, O., van der Heide, T., van Dam, A., Baron, W., de Vries, H., & Hoekstra, D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.09.012 · Cited by 72
Ulrich, R., Seeliger, F., Kreutzer, M., Germann, P. ‐., & Baumgärtner, W. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00956.x · Cited by 68
Cassiani‐Ingoni, R., Coksaygan, T., XUE, H., Reichert-Scrivner, S. A., Wiendl, H., RAO, M., & Magnus, T. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.030 · Cited by 71
Ní Fhlathartaigh, M., McMahon, J., Reynolds, R., Connolly, D., Higgins, E., Counihan, T., & FitzGerald, U. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-37 · Cited by 61
“Freund’s adjuvant (IFA; Sigma, Dublin, Ireland) according to previously described protocols [29,30].”
MethodSelf-citationSynapses between NG2 glia and neurons
Sakry, D., Karram, K., & Trotter, J. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01359.x · Cited by 65
“NG2+ glia react fast and strongly to CNS damage including demyelination, stab wounds and viral infections (Dawson et al. 2000; Reynolds et al. 2002).”
BackgroundGirolamo, F., Ferrara, G. B., Strippoli, M., Rizzi, M., Errede, M., Trojano, M., Perris, R., Roncali, L., Svelto, M., Mennini, T., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.021 · Cited by 71
“…the oligodendrocyte lineage in EAE demyelinating lesions of the spinal cord, relatively little is known about the situation in the cerebral cortex (Di Bello et al., 1999; Gensert and Goldman, 1997; Keirstead et al., 1998; Papadopoulos et al., 2010; Polito and Reynolds, 2005; Reynolds et al., 2002).”
InfluentialMarkoullis, K., Sargiannidou, I., Schiza, N., Roncaroli, F., Reynolds, R., & Kleopa, K. A. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000106 · Cited by 61
Self-citationPapadopoulos, D., Rundle, J., Patel, R., Marshall, I. C. B., Stretton, J. L., Eaton, R., Richardson, J. C., González, M. I., Philpott, K. L., & Reynolds, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22196 · Cited by 62
“…adult female DA (RT1av1) rats (Harlan, United Kingdom; 180–190 g) with recombinant MOG (rMOG) according to a protocol modified from Storch et al. (1998). rMOG protein corresponding to the N-terminal extracellular domain of mouse MOG (1–116 a.a.) was prepared as described by Reynolds et al. (2002).”
MethodSelf-citationNeural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis
Xiao, J., Yang, R., Biswas, S., Zhu, Y., Qin, X., Zhang, M., Zhai, L., Luo, Y., He, X., Mao, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0566-7 · Cited by 62
“These OPCs are present in robust densities inside the lesions during early phases of MS pathology [46], although in chronic MS lesions, their number becomes significantly lower [47, 48].”
BackgroundNG2-positive glia in the human central nervous system
Staugaitis, S. M., & Trapp, B. D. (2009) · Neuron Glia Biology · doi:10.1017/s1740925x09990342 · Cited by 58
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
Rivera, F. J., & Aigner, L. (2012) · Biological Research · doi:10.4067/s0716-97602012000300007 · Cited by 53
“…OPCs (Niehaus et al., 2000), the majority of data supports a failure of OPC differentiation and maturation in MS. OPCs are typically found in demyelinated areas, but they fail to diff erentiate and to remyelinate (Chang et al., 2002; Kuhlmann et al., 2008; Reynolds et al., 2002; Wolswijk, 1998).”
Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
Blanchard, B., Heurtaux, T., Garcia, C., Moll, N. M., Caillava, C., Grandbarbe, L., Klosptein, A., Kerninon, C., Frah, M., Coowar, D., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-13.2013 · Cited by 51
“For NG2 staining, positive cells with DAPI nuclei were quantified and separated from each other using high-resolution fluorescence microscopy as reported previously (Reynolds et al., 2002; Dawson et al., 2003).”
MethodKremer, D., Heinen, A., Jadasz, J. J., Göttle, P., Zimmermann, K., Zickler, P., Jander, S., Hartung, H.-P., & Küry, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900204106 · Cited by 57
“In this study, we demonstrate that the p57kip2 gene is regulated during the course of MOG-induced experimental autoimmune encephalomyelitis (EAE), a model that shares many pathological features with MS, including partial remyelination (16, 17).”
BackgroundRobinson, A. P., Rodgers, J. M., Goings, G. E., & Miller, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107649 · Cited by 52
“There are a number of experimental rodent models of demyelinating disease including cuprizone-induced demyelination and experimental autoimmune encephalomyelitis (EAE), and remyelination has been described in both of these models [5,6].”
BackgroundCalzà, L., Fernández, M., Giuliani, A., D’Intino, G., Pirondi, S., Sivilia, S., Paradisi, M., DeSordi, N., & Giardino, L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.022 · Cited by 56
Gao, Q., Lü, J., Huo, Y., Baby, N., Ling, E., & Dheen, S. T. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.022 · Cited by 54
Kaneko, N., Kako, E., & Sawamoto, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00235 · Cited by 53
“After demyelination, new oligodendrocytes generated from the parenchymal OPCs contribute to remyelination (Reynolds et al., 2002; Aguirre et al., 2007; Fancy et al., 2009, 2011; Patel et al., 2010; Azim and Butt, 2011; Huang et al., 2011; Mi et al., 2011).”
BackgroundFibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo
Butt, A. M., & Dinsdale, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.007 · Cited by 55
Mela, A., & Goldman, J. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3075-09.2009 · Cited by 51
“Recent studies have focused on their responses to demyelination (Keirstead et al., 1998; Reynolds et al., 2002), their interactions with neurons (Bergles et al.”
BackgroundUpregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease
Papadopoulos, D., Ewans, L., Pham-Dinh, D., Knott, J., & Reynolds, R. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.01.007 · Cited by 49
Self-citationMicroRNAs in oligodendrocyte development and remyelination
Ngo, C., & Kothary, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15618 · Cited by 44
“These findings suggest that the stages of oligodendrocyte progression on which miR- 125a- 3p acts upon vary depending on conditions of differentiation, for example, the increase in the rate of OPC differentiation that occurs after CNS damage (Reynolds et al., 2002).”
BackgroundAxon–glia synapses are highly vulnerable to white matter injury in the developing brain
Shen, Y., Liu, X., Pleasure, D., & Deng, W. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22722 · Cited by 48
“…consistent with previous findings showing that OPCs in areas of demyelinated lesions display a degenerative morphology (Cenci di Bello et al., 1999; Reynolds et al., 2002) and that vGluT1 and vGluT2 have differential distributions and functions in the brain (Fremeau et al., 2004a,b; Graziano et…”
Huang, S., Ding, Y., Ruan, J., Zhang, W., Wu, J., He, B., Zhang, Y., Li, Y., & Zeng, Y. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.03.010 · Cited by 46
Moransard, M., Dann, A., Staszewski, O., Fontana, A., Prinz, M., & Suter, T. B. (2011) · Brain · doi:10.1093/brain/awr070 · Cited by 47
“…cause extensive CNS damage including axonopathy and demyelination, events that trigger substantial oligodendrocyte progenitor cell activation and glial scar formation (Di Bello et al., 1999; Reynolds et al., 2002; Alonso, 2005; Foote and Blakemore, 2005; Rhodes et al., 2006; Mildner et al., 2009).”
BackgroundLinker, R. A., & Lee, D.-H. (2009) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-1-5 · Cited by 43
de Jong, J. M., Wang, P., Oomkens, M., & Baron, W. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24582 · Cited by 48
Disease-Responsive Neural Precursor Cells are Present in Multiple Sclerosis Lesions
Snethen, H., Love, S., & Scolding, N. J. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.835 · Cited by 43
D’Intino, G., Lorenzini, L., Fernández, M., Taglioni, A., Perretta, G., Vecchio, G. D., Villoslada, P., Giardino, L., & Calzà, L. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02181.x · Cited by 40
Spaas, J., Franssen, W. M. A., Keytsman, C., Blancquaert, L., Vanmierlo, T., Bogie, J. F. J., Broux, B., Hellings, N., van Horssen, J., Posa, D. K., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02306-9 · Cited by 40
“Oligodendrocyte dysfunction, death and demyelination may therefore underlie the reduction in Carns1 expression seen in acute EAE [64].”
BackgroundThe remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis
Jadasz, J. J., Aigner, L., Rivera, F. J., & Küry, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1331-x · Cited by 43
“2 (Fancy et al. 2004; Levine and Reynolds 1999; Reynolds et al. 2002).”
BackgroundInduction of angiopoietin-2 after spinal cord injury
Durham-Lee, J. C., Wu, Y., Mokkapati, V. U. L., Paulucci-Holthauzen, A. A., & Nesic, O. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.058 · Cited by 37
“It has been well established that NG2-labeled OPCs generate myelinating oligodendrocytes (Horner et al., 2000; Nishiyama et al., 2002; Reynolds et al., 2002), whose contribution to the functional recovery after SCI is well established (Jiang et al.”
Payne, S. C., Bartlett, C. A., Savigni, D. L., Harvey, A. R., Dunlop, S. A., & Fitzgerald, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065710 · Cited by 40
“The NG2+/olig2+/CC1+ population is thought to represent a brief transitional stage [42] and this population was not directly quantified in the current study.”
BackgroundStimulation of Adult Oligodendrogenesis by Myelin-Specific T Cells
Nielsen, H. H., Toft‐Hansen, H., Lambertsen, K. L., Owens, T., & Finsen, B. R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.006 · Cited by 37
CCL11 promotes migration and proliferation of mouse neural progenitor cells
Wang, F., Baba, N., Shen, Y., Yamashita, T., Tsuru, E., Tsuda, M., Maeda, N., & Sagara, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0474-9 · Cited by 37
“The OPCs migrate to sites of injury and differentiate into mature oligodendrocytes [39, 40].”
BackgroundMacroglial diversity: white and grey areas and relevance to remyelination
Werkman, I. L., Lentferink, D. H., & Baron, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03586-9 · Cited by 37
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
“In general, after appropriate cues from their milieu, OPCs undergo asymmetric division and migrate towards the lesion site, guided by chemoattractant factors such as Semaphorin 3F (Reynolds et al., 2002; Galloway et al., 2019).”
BackgroundSelf-citationCasamassa, A., Rocca, C. L., Sokolow, S., Herchuelz, A., Matarese, G., Annunziato, L., & Boscia, F. (2016) · Glia · doi:10.1002/glia.22985 · Cited by 34
“…with our findings, several studies indicate that when adult OPCs attempt to repair myelin, they expand during the early stages of EAE (Girolamo et al., 2011; 1134 Volume 64, No. 7 Robinson et al., 2014), thereby repopulating the lesion site throughout the progression of EAE (Reynolds et al., 2002).”
BackgroundResultInfluentialKeiner, S., Niv, F., Neumann, S., Steinbach, T., Schmeer, C. W., Hornung, K., Schlenker, Y., Förster, M., Witte, O. W., & Redecker, C. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0347-2 · Cited by 33
Kopec, B. M., Kiptoo, P. K., Zhao, L., Rosa‐Molinar, E., & Siahaan, T. J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00644 · Cited by 34
“45,46 In our case, the mice treated with BDNF + ADTC5 showed a significant increase in both myelin density, as determined by Luxol fast blue (Figure 2A,B) and NG2 presence in the corpus callosum, as indicated by immunohistochemistry staining (Figure 3A,B) compared to the mice that received BDNF…”
ResultKern, J., Schrage, K., Koopmans, G. C., Joosten, E. A. J., McCaffery, P. J. A., & Mey, J. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.11.006 · Cited by 32
“These reactions are triggered by demyelination (Keirstead et al., 1998; Dawson et al., 2003), axonal degeneration (Nielsen et al., 2006) and signals from macrophages and platelets, including the cytokines IFNg, IL-1a, TNFa and TGFb (Rhodes et al., 2006).”
BackgroundDaynac, M., Chouchane, M., Collins, H. Y., Murphy, N. E., Andor, N., Niu, J., Fancy, S. P. J., Stallcup, W. B., & Petritsch, C. K. (2018) · Nature Communications · doi:10.1038/s41467-018-05099-3 · Cited by 30
Metadata
- Authors
- Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J.
- Affiliations
- Imperial College London (GB)
- Inserm (FR)
- Stony Brook University (US)
- Venue
- Journal of Neurocytology
- Published
- 2002-07
- Volume
- 31
- Issue
- 6-7
- Pages
- 523-536
- ISSN
- 0300-4864 (ISSN-L)
- 1573-7381
- OpenAlex
- W1536744532
- Cited by
- 175
- References
- 49
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 7 · 2013: 15 · 2012: 12
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Neurocytology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- oligodendrocyte precursor cells, remyelination, demyelination, multiple sclerosis, experimental autoimmune encephalomyelitis, myelin oligodendrocyte glycoprotein, CNP, oligodendrocyte differentiation, relapse, chronic demyelination, spinal cord lesions, microglia
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Animals, Antigens, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Gliosis, Humans, Middle Aged, Multiple Sclerosis, Myelin Proteins, Myelin Sheath, Nerve Regeneration, Oligodendroglia, Proteoglycans, Recombinant Fusion Proteins, Stem Cells, Biomarkers, Myelin-Associated Glycoprotein, Cell Lineage, Rats, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.